EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice

Yanwen Zhang, Qian Wang, Shuangyong Sun iD, Lingyan Jiang

PLOS ONE · 29.08.2023 · 18 (8) · e0290637

DOI: 10.1371/journal.pone.0290637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 29.08.2023. Verfasst von Yanwen Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy,Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Psoriasis, Glycyrrhetinic Acid. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycyrrhetinic acid, a drug with anti-inflammatory effects, enhanced the activity of antipsoriatic efficacy. In this research, an ointment with glycyrrhetinic acid was prepaired as the major component and several other herbal monomers (astilbin, osthole, and momordin Ic) have antipsoriatic activity as minor components. Then an Imiquimod-induced psoriasis-like mouse model was established and the damaged skin condition of the administered group, the changes in the spleen index and the secretion of inflammatory factors in mouse skin were observed. Calcipotriol ointment was used as a positive control to compare the efficacy. Glycyrrhizic acid compound ointment significantly improved imiquimod-induced psoriasis in mice and reduced the secretion of TNF-α, IL-12, IL-17, and IL-23 in mouse skin, and showed a stronger therapeutic effect than calcipotriol ointment. Calcipotriol ointment did not significantly alleviate imiquimod-induced splenomegaly and did not significantly reduce the expression of IL-17 and IL-23 in mouse skin. Glycyrrhetinic acid compound ointment was more effective than calcipotriol and was dose-dependent in the treatment of imiquimod-induced psoriatic dermatitis in mice. Meanwhile,calcipotriol was not suitable for the treatment of Imiquimod -induced psoriasis-like mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisGlycyrrhetinic AcidAnimalsMiceGlycyrrhizic AcidImiquimodInterleukin-17OintmentsInterleukin-23

Substanzen

Glycyrrhizic AcidImiquimodInterleukin-17OintmentsGlycyrrhetinic AcidInterleukin-23

Autor:innen und Institutionen

  • School of Pharmacy,Tianjin Medical University, Tianjin, China.
  • TEDA Institute of Biological Sciences and Biotechnology, Nankai University, Tianjin, China.

ORCID-Profile: Shuangyong Sun

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Wang, Q., Sun, S., & Jiang, L. (2023). The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice. PLOS ONE, 18(8), e0290637. https://doi.org/10.1371/journal.pone.0290637

Vancouver

Zhang Y, Wang Q, Sun S, Jiang L. The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice. PLOS ONE. 2023;18(8):e0290637. doi:10.1371/journal.pone.0290637

BibTeX
@article{Zhang2023,
  author = {Zhang, Yanwen and Wang, Qian and Sun, Shuangyong and Jiang, Lingyan},
  title = {The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {8},
  pages = {e0290637},
  doi = {10.1371/journal.pone.0290637}
}
Kostenlos starten →